including cancer, vaccines, a review of measures regulating the prices of medicinal products, health in the Mediterranean area, and work with health care organisations. Read more…
Despite no specific mention of liver disease, this is a huge part of the Horizon 2020 agenda so research projects linking liver disease to diabetes or retinal disease should be considered. Read more....
Tell everyone you meet this week about the organ donor register and save lives
Now 4028 members from 106 countries
EASL Governing Board
Prof. Mark Thursz
Prof. Mark Thursz

Before joining the EASL Governing Board, British Professor Mark Thursz, MD FRCP, Professor of Hepatology, was very active on a national level in promoting the interests of Hepatology as a speciality and, perhaps more importantly, promoting the interests of patients. His research and clinical interests in genetics, viral hepatitis, fibrosis and NAFLD complement the interests of other EASL Governing Board members.

For three years, Mark Thursz was the Secretary of the British Association for Study of the Liver (BASL) during which he campaigned for a National Service Framework for liver disease and co-wrote the National Plan for Liver Services which is now implemented by the UK Department of Health. Since then, he established and now chairs the British Liver Disease Clinical Interest Group which coordinates multicentre clinical research in liver disease across the UK.

Mark has shown skills and experience throughout his 2 years as EASL Vice-Secretary that have led to advance the cause of Hepatology at European level. As of April 2011, he stepped into the position of EASL Secretary General that he will hold for 2 consecutive years.

Prof. Mark Thursz
Department of Hepatology
Imperial College London
St Mary's Campus
Norfolk Place
London, W2 1NY
United Kingdom

Tel: +44(0)207 886 1903